Letter re: "Cyclosiloxanes produce fatal liver and lung damage in mice". by Lukasiak, J et al.
Correspondence
According to Lieberman et al. (1), the
LD50 for the distillate was 28 g/kg body
weight; for D4, a component of the mix-
ture, the LD 0 was 6-7 g/kg. According to
the first edition of the now classical
Casarett's and Doull's Toxicology (3), such
values are not characteristic for highly toxic
compounds. As a matteroffact, agents hav-
ing an LD50of5-15 g/kg are usually classi-
fied as slightly toxic, and those having an
LD50 of> 15 g/kg are labeled practically
nontoxic. The latest edition of Casarettand
Doull's Toxicology (4) no longer carries this
classification, but provides the following on
the spectrum oftoxic doses:
Some chemicals produce death in microgram
doses and are commonly thought of as being
extremely poisonous. Other chemicals may be
relatively harmless after doses in excess ofseveral
grams.
An accompanying table (4) lists the LD50
values for ethyl alcohol and sodium chlo-
ride as 10 g/kg and 4 g/kg, respectively.
These are values similar to those found for
the cyclosiloxanes. Alcohol and salt are
freely available in many homes, supermar-
kets, and restaurants and are usually not
perceived as being highly toxic. Lieberman
et al. (1) also compared the toxicity of the
cyclosiloxanes to the toxicity of carbon
tetrachloride and trichloroethylene.
Carbon tetrachloride has been identified as
moderately toxic to laboratory animals (5),
and trichloroethylene called relatively non-
toxic (6). Clearly, there is a considerable
discrepancy between the usual toxicity clas-
sification and the descriptors used by
Lieberman et al. (1).
It is also not justified to ascertain that
cyclosiloxanes arewidelydistributed follow-
ing subcutaneous injection. In their previ-
ous paper (2), Lieberman and colleagues
deposited 250 mg of breast implant distil-
late subcutaneously in the suprascapular
area ofmice. They then measured total and
individual cyclosiloxanes in 10 organs and
tissues up to 1 year after treatment. Again,
the data are credible. Unfortunately, how-
ever, the paper (2) fails to provide data on
mass balance, which is considered to be a
de rigeur requirement in distribution stud-
ies. Nevertheless, from Figure 2B [Kala et
al. (2)] it can be estimated that the average
concentration of total cyclosiloxanes 6
weeks after the injection, when maximum
values were obtained, is approximately 6
pg/g wet tissue. Assuming that there is a
uniform concentration ofcyclosiloxanes in
all tissues (an assumption which overlooks
the fact that the highest cyclosiloxane con-
centrations were found in tissues which
contribute little to overall body mass such
as lymph nodes, uterus, and ovaries,
whereas liver had < 1 pg/g and skeletal
muscle approximately 6 pg/g), it then can
be calculated that the total body burden
away from the site of injection in a 25-g
mouse would have been 150 pg cyclosilox-
anes. This represents < 0.1% of all the
material deposited in the suprascapular
region. Where is the rest of the material?
In the absence ofa mass balance sheet that
would provide complete data on distribu-
tion (and possible excretion) of the
cyclosiloxanes, we must assume that
> 99.9% ofthe injected material never left
the site ofdeposition. Given these facts, it
simply cannot be stated that "they are dis-
tributed widely." They are not.
The available evidence on the toxicity
of silicones was recently reviewed by two
independent bodies (7,8). The National
Science Panel (7) concluded that
The results of this review indicate that the sili-
cones used in silicone breast implants are ofvery
low toxicity to animals. Although there is docu-
mented evidence oflocal inflammatory reactions
to silicone breast implant material in animals,
there is no convincing evidence for a significant
systemic inflammatory response.
The Independent Review Group (8) stated
The information supplied about the local and sys-
temic toxicity, genetic toxicity, reproduction toxi-
city and carcinogenicity testing showed that they
were all relatively bland substances in a range of
animal and in vitro tests.... Tests looking with
reliable, validated analytical techniques for the
dissemination of silicones from implants in the
body, including breakdown products ofthepoly-
mers, have shown either no dissemination, or the
presence ofonly very small amounts at distant
sites following rupture ofgel-filled implants, or
after deliberate injection ofthegel.
Clearly, the findings by Lieberman et
al. (1,2)-and there is no reason not to
believe their data-would much better sup-
port the conclusions drawn by two recent
review groups rather than their own inter-
pretation of their data. Thus, terms used
such as highly toxic and widely distributed
are ofconcern. Given the actual data, these
descriptors are not in line with current
valid and thoroughly validated concepts of
toxicology. They may be misused because,
taken out ofcontext without the accompa-
nying hard data, they will lead to serious
misrepresentations ofthe hazards associated
with silicone breast implants.
HanspeterWitschi
Institute ofToxicology and
Environmental Health
University ofCalifornia
Davis, California
E-mail: hrwitschi@ucdavis.edu
REFERENCES AND NOTES
1. Lieberman WM, Lykissa ED, Barrios R, Ou CN, Kala
G, Kala SV. Cyclosiloxanes produce fatal liver and
lung damage in mice. Environ Health Perspect
107:161-165(1999).
2. Kala SV, Lykissa ED, Neely MW, Lieberman MW
Low molecular weight silicones are widely distrib-
uted after a single subcutaneous injection in mice.
Am J Pathol 152: 645-649(1998).
3. Casarett LJ, Doull JD, eds. Toxicology. The Basic
Science of Poisons. 1st ed. New York:Macmillan,
1975.
4. Klaassen DC, Amdur MO, Doull J, eds. Casarett and
Doull's Toxicology: The Basic Science of Poisons.
5th ed. NewYork:McGraw-Hill, 1996.
5. Roble H. Carbon tetrachloride. In: Encyclopedia of
Toxicology (Wexler P, ed), Vol 1. San Diego, CA:
Academic Press, 1998;227-228.
6. Parent RA, Klein TR, Sharpe DE. Trichloroethylene.
In: Encyclopedia ofToxicology (Wexler P, ed), Vol 3.
San Diego, CA:Academic Press, 1998;372-374.
7. Diamond BA, Hulka BS, Kerkvliet NI, Tugwell P.
Silicone Breast Implants in Relation to Connective
Tissue Diseases and Immunologic Dysfunction. A
report by a National Science Panel tothe Honorable
Sam C. Pointer, Jr., coordinating judge forthe feder-
al breast implant multidistrict litigation. U.S. District
Court for the Northern District of Alabama,
Birmingham, AL, 17 November 1998.
8. Silicone Gel Breast Implants. The Report of the
Independent Review Group. Cambridge, UK:Jill
Rogers Associates, 1998.
We read with great interest the paper by
Lieberman et al. (1) on the toxicity of
cyclosiloxanes. In addition to their impor-
tant observations, it should be noted that
siloxanes, as dimethicone [British Pharma-
copeia (2)] or simethicone [U.S. Phar-
macopeia (3)], are used, for example, to
treat intestinal gas in humans. They are
mixtures ofboth linear (polydimethylsilox-
anes; PDMS), as the main component, and
cyclic siloxanes (cyclopolydimethylsilox-
anes; cPDMS) ofdifferent molecular mass-
es. For drugs registered in Poland, the cur-
rent producers' information on sime-
thicone- or dimethicone-based drugs stated
that the drugs are not completely absorbed
in the intestine and some ofthem permit a
daily intake as high as 400-640 mg/day.
To verify the statements, we recently
performed a placebo-controlled study on
intestinal absorption of siloxanes in rats
(4). We examined the blood ofWistar rats
fed 12 days with a granulated feed diet
without siloxanes (LSM; Wytwornia Pasz
w Motyczu, Poland) with added 5%
PDMS (n = 5 animals), 5% cPDMS oil (n
= 5), orwithout siloxanes (n = 5). Viscosity
and molecular mass of siloxanes tested
were equal to those most frequently used
in oral drugs [viscosity of 300 centistokes
(cST), which reflects molecular mass of
about 15,000 Da; 1 cST = 10-6 m2/sec].
All animals used in the research were treat-
ed humanely according to Medical
University of Gdansk institutional guide-
lines. The silicones were extracted from the
rats' blood and quantitatively measured
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with 'H nuclear magnetic resonance
(NMR) technique using an internal con-
trol (5). Blood samples from animals given
feed without siloxanes showed no signals
originating from the silicones tested. In all
blood samples from animals given feed
with siloxanes, they were detected. In sam-
ples from animals given feed with PDMS,
the mean concentration (± standard devia-
tion) of siloxanes of 26 ± 14 pg/cm3 was
noted; in samples from animals given feed
with cPDMS, the mean concentration of
siloxanes of 70 ± 97 pg/cm3 was noted.
The difference was not significant. These
results conform well to those obtained pre-
viously in Rhesus monkeys by Calandra et
al. (6). In our opinion, the absorption and
toxicity of siloxane-based drugs should be
more intensively studied.
Our study was supported by the Polish
State Committee for Scientific Research
(KBN) (grant4P05D06612).
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In their recent publication, Lieberman et
al. (1) described the acute toxicity in mice
after intraperitoneal injection of distillates
containing either a mixture of cyclosilox-
anes or a component ofthe mixture's distil-
late (octamethylcyclotetrasiloxane). The
dose levels in the series of studies ranged
from 3.5 to 35 g/kg. The median lethal
dose of the distillate was 28 g/kg, or 1.68
kgfor a60-kghuman.
The authors drew sweeping conclusions
regarding this class ofchemicals based on a
minimalist investigation of toxicity. The
acute doses administered by the intraperi-
toneal route were clearly excessive and were
much greater than the limit doses recom-
mended by the U.S. Environmental
Protection Agency (EPA) and the
Organisation for Economic Co-operation
and Development (OECD) as maximum
dose levels in studies ofthis type. Few com-
pounds are tested at dose levels this high
because of concerns regarding unnecessary
pain and suffering ofanimals. A basic tenet
of toxicology is that all chemicals have the
potential to be toxic atsufficiendy high dose
levels. The toxicity observed after adminis-
tering extremely high dose levels is not use-
ful for comparative purposes (because few
compounds are tested at such high levels) or
for risk assessment (because the dose levels
are so much greater than potential human
exposures to the agents ofconcern). Acute
lethal studies conducted by the intraperi-
toneal route deliver a bolus dose with the
equivalent of 100% absorption. Lethality is
not a surprising finding under these condi-
tions and would be observed with table salt
and other substances generally considered to
be innocuous.
Furthermore, the conclusion that cyclic
siloxanes are similar in toxicity to carbon
tetrachloride and trichloroethylene is
unfounded. The no-observed-adverse-effect
level (a standard benchmark oftoxicity) for
carbon tetrachloride that has been used to
set a drinking water standard is 1.0
mg/kg/day in a 12-week gavage study in
rats (2). This was 3,500 times less than the
lowest level used by Lieberman and col-
leagues (1). They did not present any evi-
dence that carbon tetrachloride and
trichloroethylene share a common mecha-
nism oftoxicitywith the siloxanes.
In summary, the publication of
Lieberman et al. (1) does not advance our
understanding ofthe toxicity ofthis class of
compounds. The paper is likely to be cited
by plaintiffs in tort cases, but the study
results are oflimited use to those ofus who
are concerned with the safety evaluation
and risk assessment ofthese substances.
GaryJ. Burin
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I recently read the paper "Cyclosiloxanes
Produce Fatal Liver and Lung Damage in
Mice" (1). Although siloxanes are not a par-
ticular interest of mine, I was curious.
Lieberman et al. (1) administered the dis-
tilled mix at a rate of 3.5-35 g/kg body
weight. As a toxicologist, I was intrigued
because 35 g/kg is 3.5% of body weight,
injected intraperitoneally yet! Toxicolog-
ically, such a dose is akin to hitting the
mouse with a stick. Lieberman et al. report-
ed that "some or all of the components of
the distillate are lethal, with an LD50 for the
distillate ofabout 28 g/kg." Do we ever find
a substance that is not lethal at some dose?
Lieberman et al. (1) then make the fol-
lowing statement:
Our data demonstrate that a mixture of low-
molecular-weight CSs contained in breast
implants is highly toxic and that at least one spe-
cific compound, CS-D4, is toxic as well.
Highly toxic indeed!
Five grams per kilogram is usually con-
sidered virtually nontoxic in the world of
pesticides, and here we are told that 28
g/kg is highly toxic. CS-D4 comes a bit
closer at 6-7 g/kg. There appears to be a
three-order-of-magnitude nomenclature
problem here.
The finding ofhydroxyl radical forma-
tion as a result of treatment with CS-D4
sparked a moment of interest, which died
when I saw that the animals were given a
lethal dose, and no dose-response informa-
tion was obtained. [Lieberman et al.'s
Figure 4 (1) does not disclose the dose, but
itwas found in text, fortunately nearby.]
It also occurred to me that there was
some missing context. Lieberman et al. (1)
did not explain what fraction ofan implant
actually can be extracted in such a distillate,
even though they quoted an earlier paper
with that information (2). Approximately
1% of the implant can be considered
mobile, if distillation describes mobility.
Mobilization in vivo is obviously slow,
unlike the intraperitoneal assault on the
mice.
I am curious about the point of this
paper. I do not follow the implant prob-
lem, but I know that it is highly charged
politically and emotionally. As the newspa-
pers tell us, implants are litogenic and pro-
duce much exercise for the courts. The
only conclusion I can draw is that the ter-
minology here is political. It is the kind of
rhetoric that comes from activists who
ignore science.
It is important to learn what happens
to this foreign material placed in the body
and to try to track the biological interac-
tions. Lieberman et al. (1) make a small
contribution, but I predict that this paper
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